Medicare – Page 9 – Policy & Medicine

January MedPAC Recommendations: Rebates & Biosimilars

PhRMA Submits Comments on CMS Proposed Rule Regarding Modernizing Part D and Medicare Advantage

CMS Releases MA and Part D Advance Notice and Draft Call Letter

Voluntary Part D Demo Incentivizes Plans to Reduce Spending on High-Cost Drugs

CMMI Announces Plans to Expand Medicare Advantage Model

The Trump Administration Has Had an Active Few Weeks in the Drug Pricing Arena

CMS Issues Proposed Rule Focused on Part D and MA Drug Prices

Law Passed to Crack Down on Chinese Fentanyl Traffickers

CMS Posts 2019 Physician Fee Schedule includes changes to Medicare Part B Drug Payments and Telehealth Reimbursement

CMS Submits Part D and Medicare Advantage Drug Pricing Proposal to Office of Management and Budget